Key milestone achieved as Company advances clinical program to full approval trial of ateganosine sequenced with a checkpoint inhibitor in ...
After nearly 30 years of planning, the University of South Dakota Discovery District now provides lab and office space to ...
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences. From high-stakes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback